Recurrent Verrucous Carcinoma of the Larynx Withdrawn Phase 2 Trials for Echinacea (DB14240)

IndicationStatusPhase
DBCOND0029506 (Recurrent Verrucous Carcinoma of the Larynx)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01674374Botanical Therapy in Treating Mucositis in Patients With Head and Neck Cancer Who Have Undergone Chemoradiation TherapySupportive Care